529 related articles for article (PubMed ID: 16020880)
1. Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002.
Tanaka K; Kujuro Y; Suzuki S; Tanahashi N; Hamada J; Nogawa S; Suzuki N
Intern Med; 2005 Jun; 44(6):560-6. PubMed ID: 16020880
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of patients with late-onset multiple sclerosis.
Kis B; Rumberg B; Berlit P
J Neurol; 2008 May; 255(5):697-702. PubMed ID: 18283394
[TBL] [Abstract][Full Text] [Related]
3. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
[TBL] [Abstract][Full Text] [Related]
4. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
[TBL] [Abstract][Full Text] [Related]
5. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
[TBL] [Abstract][Full Text] [Related]
7. Opticospinal multiple sclerosis in Iran.
Kalanie H; Kholghie Y; Shamsai GR; Ghorbani M
J Neurol Sci; 2009 Jan; 276(1-2):130-2. PubMed ID: 18962726
[TBL] [Abstract][Full Text] [Related]
8. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
[TBL] [Abstract][Full Text] [Related]
9. CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients.
Joseph FG; Hirst CL; Pickersgill TP; Ben-Shlomo Y; Robertson NP; Scolding NJ
J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):292-6. PubMed ID: 18829628
[TBL] [Abstract][Full Text] [Related]
10. Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.
Annunziata P; Giorgio A; De Santi L; Zipoli V; Portaccio E; Amato MP; Clerici R; Scarpini E; Moscato G; Iudice A; Vacca G; Orefice G; Morra VB; Maimone D
J Neurol Sci; 2006 May; 244(1-2):97-102. PubMed ID: 16473370
[TBL] [Abstract][Full Text] [Related]
11. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
[TBL] [Abstract][Full Text] [Related]
12. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
[TBL] [Abstract][Full Text] [Related]
13. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
14. Brain volume in early MS patients with and without IgG oligoclonal bands in CSF.
Fenu G; Lorefice L; Sechi V; Loi L; Contu F; Cabras F; Coghe G; Frau J; Secci MA; Melis C; Schirru L; Costa G; Melas V; Arru M; Barracciu MA; Marrosu MG; Cocco E
Mult Scler Relat Disord; 2018 Jan; 19():55-58. PubMed ID: 29132035
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
Ferraro D; Galli V; Vitetta F; Simone AM; Bedin R; Del Giovane C; Morselli F; Filippini MM; Nichelli PF; Sola P
J Neuroimmunol; 2015 Jun; 283():64-9. PubMed ID: 26004159
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.
Andreadou E; Chatzipanagiotou S; Constantinides VC; Rombos A; Stamboulis E; Nicolaou C
Clin Neurol Neurosurg; 2013 Oct; 115(10):2094-8. PubMed ID: 23953642
[TBL] [Abstract][Full Text] [Related]
17. Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
Rojas JI; Patrucco L; Tizio S; Cristiano E
Arq Neuropsiquiatr; 2012 Aug; 70(8):574-7. PubMed ID: 22899026
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
[TBL] [Abstract][Full Text] [Related]
19. Increasing incidence of multiple sclerosis in women in Northern Finland.
Krökki O; Bloigu R; Reunanen M; Remes AM
Mult Scler; 2011 Feb; 17(2):133-8. PubMed ID: 20935028
[TBL] [Abstract][Full Text] [Related]
20. Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study.
Sıvacı AÖ; Seferoğlu M; Piri Çınar B; Uzunköprü C; Beckmann Y; Güngör Doğan İ; Çetinkaya Tezer D; Tunç A; Ethemoğlu Ö; Gümüş H; Açıkgöz M; Yalaz Tekan Ü; Demir S
Mult Scler Relat Disord; 2024 Apr; 84():105469. PubMed ID: 38341979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
